Literature DB >> 17083896

Kaposi sarcoma in a patient with giant cell arteritis.

Anoop Kuttikat1, Abhay Joshi, Ibtisam Saeed, Kuntal Chakravarty.   

Abstract

Kaposi sarcoma usually occurs in immunosuppressed patients. A classic type has been reported in elderly men of Jewish and Mediterranean origin. We report a case of an elderly woman with giant cell arteritis (GCA) who developed Kaposi sarcoma while on a double blind trial for GCA with an anti-tumor-necrosis-factor medication. Our patient had none of the risk factors for Kaposi sarcoma, and when she was withdrawn from the study it was found that she was receiving only placebo along with the moderate, tapering doses of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083896

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  4 in total

Review 1.  Tumor necrosis factor blockade and the risk of viral infection.

Authors:  Seo Young Kim; Daniel H Solomon
Journal:  Nat Rev Rheumatol       Date:  2010-02-09       Impact factor: 20.543

2.  Kaposi sarcoma in an patient with atopic dermatitis treated with ciclosporin.

Authors:  Dmitri Wall; Mairín McMenamin; Deirdre O'Mahony; Alan D Irvine
Journal:  BMJ Case Rep       Date:  2013-11-21

Review 3.  Kaposi sarcoma in anti-neutrophil cytoplasmic antibody-associated vasculitis: a case-based review.

Authors:  Benedict K Tiong; Arun S Singh; G Peter Sarantopoulos; Tanaz A Kermani
Journal:  Rheumatol Int       Date:  2021-02-23       Impact factor: 2.631

Review 4.  Cytokine-Targeted Therapeutics for KSHV-Associated Disease.

Authors:  Nedaa Alomari; Jennifer Totonchy
Journal:  Viruses       Date:  2020-09-28       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.